SSH Communications Security Corporation
29.1.2021 11:35:32 CET | Globenewswire | Press release
SSH is pleased to invite investors, analysts, bankers, and media to an investor call on February 2, 2021 at 10:00 EET.
In the call, SSH will provide more information about the acquisition of Deltagon, announced on January 29. Members of SSH, Deltagon, and Erillisverkot Group management teams will be present in the call.
The call is aimed at investors, analysts, bankers, and media. The presentations from the call will be made available on the SSH web site (www.ssh.com) shortly after the event.
Time: Tuesday, February 2, 2021 at 10:00 EET
Place: Video Call
To join the call, please register no later than Monday, February 1 at 14.00 EET by sending an email to jussi.mononen@ssh.com. Conference call links will be sent to registered participants during the afternoon of February 1.
SSH COMMUNICATIONS SECURITY CORPORATION
Niklas Nordström
CFO
SSH Communications Security
SSH.COM helps organizations access, secure, and control their digital core – their critical data, applications, and services. We have over 3,000 customers worldwide, including 40 percent of Fortune 500 companies, many of the world's largest financial institutions, and major organiza-tions in all verticals. We are committed to helping our customers thrive in the cloud era with solutions that offer secure access with zero inertia, zero friction, and zero credentials risk. SSH.COM sells online; through offices in North America, Europe, and Asia; and through a global network of certified partners. The company's shares (SSH1V) are quoted on the NASDAQ Helsinki. For more information, visit www.ssh.com.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
Rocket Lab Corporation28.3.2026 11:39:53 CET | Press release
Rocket Lab Successfully Launches 85th Mission and First Dedicated Launch for European Space Agency
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
